BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10536875)

  • 21. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.
    Franchi M; Vullo D; Gallori E; Pastorek J; Russo A; Scozzafava A; Pastorekova S; Supuran CT
    J Enzyme Inhib Med Chem; 2003 Aug; 18(4):333-8. PubMed ID: 14567548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
    Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
    Vullo D; Franchi M; Gallori E; Pastorek J; Scozzafava A; Pastorekova S; Supuran CT
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1005-9. PubMed ID: 12643899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2377-81. PubMed ID: 25913118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors: ureido and thioureido derivatives of aromatic sulfonamides possessing increased affinities for isozyme I. A novel route to 2,5-disubstituted-1,3,4-thiadiazoles via thioureas, and their interaction with isozymes I, II and IV.
    Scozzafava A; Supuran CT
    J Enzyme Inhib; 1998 Apr; 13(2):103-23. PubMed ID: 9629531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
    Sethi KK; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5168-74. PubMed ID: 23867389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):982-8. PubMed ID: 26803577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes.
    Supuran CT; Scozzafava A; Saramet I; Banciu MD
    J Enzyme Inhib; 1998 Jun; 13(3):177-94. PubMed ID: 9629536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
    Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors.
    Winum JY; Cecchi A; Montero JL; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3302-6. PubMed ID: 15908201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
    Scozzafava A; Supuran CT
    J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of novel acridine and bis acridine sulfonamides with effective inhibitory activity against the cytosolic carbonic anhydrase isoforms II and VII.
    Ulus R; Yeşildağ I; Tanç M; Bülbül M; Kaya M; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(18):5799-805. PubMed ID: 23910989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
    Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
    Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors.
    Chiaramonte N; Bua S; Angeli A; Ferraroni M; Picchioni I; Bartolucci G; Braconi L; Dei S; Teodori E; Supuran CT; Romanelli MN
    Bioorg Chem; 2019 Oct; 91():103130. PubMed ID: 31374520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT
    Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
    Vullo D; Franchi M; Gallori E; Antel J; Scozzafava A; Supuran CT
    J Med Chem; 2004 Feb; 47(5):1272-9. PubMed ID: 14971907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.